Latest NewsYesterday NewsQuote ListTopic ListQuote List
Reuters
2023.09.27 23:06

Medicinova Announces Results Of Studies Under BARDA Contract To Develop MN 166 (Ibudilast)

Sept 27 (Reuters) - MediciNova Inc (MNOV.O) : * MEDICINOVA ANNOUNCES RESULTS OF STUDIES UNDER BARDA CONTRACT TO DEVELOP MN 166 (IBUDILAST) AS A MEDICAL COUNTERMEASURE AGAINST CHLORINE GAS-INDUCED LUNG INJURY * MN-166 (IBUDILAST) WAS WELL TOLERATED AND NO SAFETY CONCERNS WERE OBSERVED IN SINGLE-DOSE STUDY
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Like